RU99125768A - COMPOSITION FOR PREVENTION OF PREGNANCY CONTAINING CONDENSATION POLYMER - Google Patents

COMPOSITION FOR PREVENTION OF PREGNANCY CONTAINING CONDENSATION POLYMER

Info

Publication number
RU99125768A
RU99125768A RU99125768/14A RU99125768A RU99125768A RU 99125768 A RU99125768 A RU 99125768A RU 99125768/14 A RU99125768/14 A RU 99125768/14A RU 99125768 A RU99125768 A RU 99125768A RU 99125768 A RU99125768 A RU 99125768A
Authority
RU
Russia
Prior art keywords
condensation polymer
composition
polymer
kda
weight
Prior art date
Application number
RU99125768/14A
Other languages
Russian (ru)
Other versions
RU2203672C2 (en
Inventor
Эндрю Дж. СОНДЕРФЕН
Алберт Т. ПРОФИ
Тони ЧЕНСЕЛЛОР
Марго МАККИНЛЕЙ
Original Assignee
Просепт, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/847,019 external-priority patent/US5958399A/en
Application filed by Просепт, Инк. filed Critical Просепт, Инк.
Publication of RU99125768A publication Critical patent/RU99125768A/en
Application granted granted Critical
Publication of RU2203672C2 publication Critical patent/RU2203672C2/en

Links

Claims (16)

1. Способ предупреждения нежелательной беременности у индивидуума, включающий введение индивидууму эффективного количества состава, содержащего конденсационный полимер ароматической сульфокислоты и альдегида, или фармацевтически приемлемую соль его, в физиологически приемлемом носителе.1. A method for preventing an unwanted pregnancy in an individual, comprising administering to the individual an effective amount of a composition comprising a condensation polymer of aromatic sulfonic acid and an aldehyde, or a pharmaceutically acceptable salt thereof, in a physiologically acceptable carrier. 2. Способ по п.1, отличающийся тем, что конденсационный полимер является конденсационным полимером нафталинсульфокислоты и формальдегида. 2. The method according to claim 1, characterized in that the condensation polymer is a condensation polymer of naphthalenesulfonic acid and formaldehyde. 3. Способ по п.2, отличающийся тем, что конденсационный полимер является узко- или монодисперсным конденсационным полимером. 3. The method according to claim 2, characterized in that the condensation polymer is a narrow or monodisperse condensation polymer. 4. Способ по п.2, отличающийся тем, что конденсационный полимер имеет молекулярный вес менее примерно 50 кДа. 4. The method according to claim 2, characterized in that the condensation polymer has a molecular weight of less than about 50 kDa. 5. Способ по п.4, отличающийся тем, что конденсационный полимер имеет мол. вес 0,7-50 кДа. 5. The method according to claim 4, characterized in that the condensation polymer has a mol. weight 0.7-50 kDa. 6. Способ по п.5, отличающийся тем, что конденсационный полимер имеет мол. вес 1,3-30 кДа. 6. The method according to claim 5, characterized in that the condensation polymer has a mol. weight 1.3-30 kDa. 7. Способ по п.6, отличающийся тем, что конденсационный полимер имеет мол. вес 4-12 кДа. 7. The method according to claim 6, characterized in that the condensation polymer has a mol. weight 4-12 kDa. 8. Способ по п.2, отличающийся тем, что конденсационный полимер имеет в среднем от примерно 0,5 до примерно 2,0 сульфокислотных групп на одну ароматическую группу. 8. The method according to claim 2, characterized in that the condensation polymer has an average of from about 0.5 to about 2.0 sulfonic acid groups per aromatic group. 9. Способ по п.8, отличающийся тем, что конденсационный полимер имеет в среднем примерно 1 сульфокислотную группу на ароматическую группу. 9. The method according to claim 8, characterized in that the condensation polymer has an average of about 1 sulfonic acid group per aromatic group. 10. Способ по п.1, отличающийся тем, что состав вводится непосредственно перед половым сношением. 10. The method according to claim 1, characterized in that the composition is administered immediately before sexual intercourse. 11. Способ по п.10, отличающийся тем, что состав является гелем, кремом или пеной. 11. The method according to claim 10, characterized in that the composition is a gel, cream or foam. 12. Способ по п.11, отличающийся тем, что состав является гелем. 12. The method according to claim 11, characterized in that the composition is a gel. 13. Способ по п.11, отличающийся тем, что полимер присутствует в составе в концентрации 1-10 вес.%. 13. The method according to claim 11, characterized in that the polymer is present in the composition at a concentration of 1-10 wt.%. 14. Способ по п.13, отличающийся тем, что полимер присутствует в составе в концентрации, равной примерно 4 вес.%. 14. The method according to item 13, wherein the polymer is present in the composition at a concentration of about 4 wt.%. 15. Способ предупреждения нежелательной беременности у индивидуума, включающий вагинальное введение геля, содержащего конденсационный полимер нафталинсульфокислоты и формальдегида в количестве между примерно 1 вес.% и примерно 10 вес.%. 15. A method for preventing an unwanted pregnancy in an individual, comprising vaginally administering a gel containing a condensation polymer of naphthalenesulfonic acid and formaldehyde in an amount of between about 1 wt.% And about 10 wt.%. 16. Способ по п.15, отличающийся тем, что полимер имеет мол.вес, примерно равный 5 кДа. 16. The method according to clause 15, wherein the polymer has a molar weight of approximately 5 kDa.
RU99125768/14A 1997-05-01 1998-04-27 Method for preventing pregnancy RU2203672C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/847,019 1997-05-01
US08/847,019 US5958399A (en) 1997-05-01 1997-05-01 Sulfonic acid and aldehyde condensation polymers for preventing pregnancy

Publications (2)

Publication Number Publication Date
RU99125768A true RU99125768A (en) 2001-09-20
RU2203672C2 RU2203672C2 (en) 2003-05-10

Family

ID=25299567

Family Applications (1)

Application Number Title Priority Date Filing Date
RU99125768/14A RU2203672C2 (en) 1997-05-01 1998-04-27 Method for preventing pregnancy

Country Status (19)

Country Link
US (1) US5958399A (en)
EP (1) EP0981354B1 (en)
JP (1) JP4350805B2 (en)
KR (1) KR100567796B1 (en)
CN (1) CN1124137C (en)
AT (1) ATE269092T1 (en)
AU (1) AU732693B2 (en)
BR (1) BR9809378A (en)
CA (1) CA2288024C (en)
DE (1) DE69824580T2 (en)
DK (1) DK0981354T3 (en)
ES (1) ES2224385T3 (en)
HK (1) HK1027981A1 (en)
NZ (1) NZ500640A (en)
PT (1) PT981354E (en)
RU (1) RU2203672C2 (en)
SI (1) SI0981354T1 (en)
WO (1) WO1998048819A1 (en)
ZA (1) ZA983655B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002045706A2 (en) * 2000-12-05 2002-06-13 Quest Medicine, Inc. The use of polymers for inactivating pathogens
CN1642540A (en) * 2002-03-26 2005-07-20 东弗吉尼亚医学院 Suramin and derivatives thereof as topical microbicide and contraceptive
KR101232249B1 (en) * 2004-08-10 2013-02-12 간또 가가꾸 가부시끼가이샤 Semiconductor substrate cleaning liquid and semiconductor substrate cleaning process
WO2009108778A1 (en) * 2008-02-27 2009-09-03 Endo Pharmaceuticals Solutions Inc. Sulfonic acid and aldehyde condensation polymers for the treatment and prevention of hpv

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3842088A (en) * 1973-01-31 1974-10-15 Sandoz Ag Substituted naphtho pyrazoles
US4001229A (en) * 1974-04-04 1977-01-04 Mead Johnson & Company Alkanesulfonamido triphenylethylenes
US4416897A (en) * 1981-07-06 1983-11-22 University Of Georgia Research Foundation, Inc. Use of 8-anilino-1-naphthalenesulfonate in the uterus to prevent pregnancy
US4419366A (en) * 1981-07-06 1983-12-06 University Of Georgia Research Foundation, Inc. Use of N-(6 aminohexyl)-5-chloro-1-naphthalenesulfonamide, N-(6 aminohexyl)-5-chloro-2-naphthalenesulfonamide, or N-(6 aminohexyl)-5-bromo-2-naphthalenesulfonamide in the uterus to prevent pregnancy
US4432967A (en) * 1982-06-25 1984-02-21 National Starch And Chemical Corp. Contraceptive composition
GB8327562D0 (en) * 1983-10-14 1983-11-16 Ici Plc Contraceptive methods
US4604404A (en) * 1985-04-03 1986-08-05 A. H. Robins Company, Inc. Antiviral sulfonated naphthalene formaldehyde condensation polymers
US4735621A (en) * 1987-02-03 1988-04-05 Lasse Hessel Tubular protective device for protection against transfer of infectious matter during sexual intercourse
US5112869A (en) * 1989-04-04 1992-05-12 Sloan-Kettering Institute For Cancer Research Substituted 1-phenylnaphthalenes
US5614559A (en) * 1993-11-23 1997-03-25 Procept Inc. Compound for inhibiting HIV infectivity
AU5175996A (en) * 1995-03-15 1996-10-02 Medical College Of Hampton Roads, The Glycoconjugate inhibitors of human sperm-egg binding

Similar Documents

Publication Publication Date Title
US4474752A (en) Drug delivery system utilizing thermosetting gels
KR100767076B1 (en) Fast-dispersing dosage forms containing fish gelatin
US4474753A (en) Topical drug delivery system utilizing thermosetting gels
EP0460020B2 (en) Drug delivery compositions
US6316483B1 (en) Oxymetazoline HCI and/or chlorpheniramine maleate nasal spray compositions
CA2468845A1 (en) Stabilized reverse micelle compositions and uses thereof
WO1997025052A3 (en) Compositions comprising pvp having an average molecular weight in the range of 3,000 to 14,000 daltons
RU2004122131A (en) COMPOSITION FORMING A MATRIX CONTAINING PECTIN
CA2234426A1 (en) Antibacterial composition for oral administration
JPS6434923A (en) Aerosolization of proteinaceous remedy
RU2003104808A (en) LIQUID COMPOSITION OF METFORMINE
EP0153836A2 (en) Dry, water-foamable pharmaceutical compositions
DK1141079T3 (en) Biodegradable Low Molecular Triblock-Polyester-Polyethylene Glycol Copolymers That Have Reverse Thermal Gelling Properties
RU2001130142A (en) Pharmaceutical Compositions of Erythropoietin
KR0149029B1 (en) Anti-diarrheal composition
WO1998006379A1 (en) Pharmaceutical compositions
US5990175A (en) Prevention of migraine
KR20050000506A (en) Temperature Responsive Delivery Systems
RU99125768A (en) COMPOSITION FOR PREVENTION OF PREGNANCY CONTAINING CONDENSATION POLYMER
ATE29386T1 (en) USE OF A SULPHONATED HOMO- OR COPOLYMER OF STYRENE IN THE MANUFACTURE OF AN ANTICONCEPTIVE AGENT.
EP1326592B1 (en) Use of polyethylene glycol ( peg ) for the manufacture of a medicament for the treatment of constipation
EP0814770B1 (en) Process for the preparation of a solid pharmaceutical dosage form
RU2003106444A (en) IMMUNOMODULATING, ANTI-MICROBIAL, ANTIOXIDANT AND REGENERATIVE AGENT (ITS OPTIONS)
KR20040066548A (en) Locally administrable, sustained-release microsphere for biological active peptide and their method of preparation
WO1999027801A1 (en) Revitalisation formulation